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Sir,
Capnocytophaga spp. have a role in the pathogenesis of various forms of 
periodontal disease and systemic infections, particularly severe in neutropenic 
cancer patients. The prevalence of ?-lactam-resistant oral bacteria is increasing in 
clinical isolates [1]. All of the reported ?-lactam-resistant Capnocytophaga isolates 
are ?-lactamase-producers, but minimum inhibitory concentrations (MICs) for the 
different ?-lactams are variable [2]. The objective of the current study was therefore 
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to explain the variability in ?-lactam MIC profiles in 31 cfxA gene-positive oral 
Capnocytophaga spp. clinical isolates with various antibiotypes. This study 
investigated: (i) the presence of other ?-lactamase genes in addition to cfxA (blaCSP-1,
cepA/cblA and cfiA); (ii) the expression level of cfxA in representative isolates with 
different antibiotic phenotypes; and (iii) the potential causes of cfxA expression 
variability, including mutation(s) in cfxA genes, location of the cfxA gene on a 
plasmid or the chromosome, and detection of the prevalence of mobile genetic 
determinants [mobA, oriT, repA, ISCoc1 and transposons (Tn)] described as being 
involved in cfxA mobilisation and dissemination in Capnocytophaga spp. strains.
All 31 isolates were clearly identified as Capnocytophaga gingivalis (n = 1), 
Capnocytophaga spp. (n = 1), Capnocytophaga ochracea (n = 2), Capnocytophaga
granulosa (n = 3), Capnocytophaga leadbetteri (n = 3), Capnocytophaga 
AHN9576/AHN9798/AHN8471/ChDc/ ChDCOS43 (n = 4) and Capnocytophaga
sputigena (n = 17) by 16S rRNA gene sequencing. MIC90 and MIC50 values (MICs 
that inhibit 50% and 90% of the isolates, respectively) were all >256 mg/L for 
amoxicillin and first-and second-generation cephalosporins but were variable for 
third-generation cephalosporins. This variation in MICs for ?-lactams was not due to 
the concomitant presence of other resistance genes: the cepA/cblA and cfiA genes 
were never detected, and the blaCSP-1 gene [3] was amplified in 11/31 (35%) of cfxA-
positive Capnocytophaga isolates (Fig. 1). The presence of blaCSP-1 was not 
significantly associated with higher MICs of cefotaxime [MIC > 16 mg/L according to 
Clinical and Laboratory Standards Institute (CLSI) breakpoints (http://clsi.org/)] 
compared with the presence of cfxA only (P > 0.1). In four isolates, MICs of ?-
lactams were low (range, <0.016–2 mg/L) with a negative nitrocefin test, despite a 
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positive cfxA PCR. In 29/31 isolates, the presence of 966 bp corresponding to the 
complete sequence of cfxA was detected (27 isolates were ?-lactam-resistant but 2 
were ?-lactam-susceptible). PCR assay, sequencing and in silico analysis showed 
that the CfxA COOH-terminal region (C-ter) in two susceptible isolates was replaced 
by a glycosyltransferase (96% homology) for one and with a partial hypothetical 
efflux pump (98% homology) for the other, with 16-bp and 82-bp overlapping gene 
sequences, respectively. Replacement of the whole C-ter region of cfxA was linked 
to ?-lactamase gene inactivation, despite a positive cfxA PCR in the 5' region. Of 
note, the C-ter region of cfxA appeared to be a preferentially targeted area or 
‘hotspot’ for the acquisition of foreign genetic material.
Among the clinical isolates, 52% harboured plasmids of 3.5, 5 and/or 9 kb. PCR 
amplified Tn (77.4%), ISCoc1 (61.3%), repA (54.8%) and mobA (74.2%) that was 
related to plasmid detection (P < 0.05). This was not the case for the oriT gene 
(16.1%) (P > 0.1) (Supplementary Table S1). In the cfxA-positive Capnocytophaga
isolates, mobA and repA genes were mainly detected (100% and 94%, respectively, 
among plasmid-positive isolates) and related to plasmid detection (P < 0.05). In 74% 
of mobA-positive isolates, the mobA and cfxA region were linked by a 96-bp 
intergenic sequence mainly found in plasmid-positive strains (P < 0.01). Higher MICs
of cefotaxime (MIC > 4 mg/L) [Comite de l’Antibiogramme de la Société Française de 
Microbiologie (CA-SFM) 2013; http://www.sfm-
microbiologie.org/page/page/showpage/page_id/90.html] were significantly related to 
the presence of mobA (P = 0.0002), mobA–cfxA junction (P = 0.0015), repA (P = 
0.0003) and at least one plasmid in bacterial strains (P < 0.0001). The presence of 
blaCSP-1, oriT, ISCoc1 or Tn did not significantly influence the MICs of cefotaxime. 
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blaCSP-1 was detected on the chromosome or a plasmid and in different species of 
Capnocytophaga, indicating a large diffusion of this novel extended-spectrum ?-
lactamase among oral Capnocytophaga spp.
An unchanged complete cfxA sequence in two ?-lactam-susceptible isolates 
indicated a possible misexpression of this gene under the influence of the cfxA
genetic environment. Gene copy number as the only explanation of the expression 
variability of cfxA has already been observed [4].
The presence of the 96-bp junction mobA–cfxA sequence could be important for 
optimal expression of the cfxA gene. Higher MICs of ?-lactams were related to cfxA
overexpression arising from IS integration upstream of the coding sequence [5]. The 
diversity of plasmid profiles of Capnocytophaga isolates did not favour dissemination 
of several different ?-lactam resistance genes via a single plasmid. In the current 
study, the cfxA gene could be located on a plasmid or/and the chromosome, 
whatever the species or MIC of ?-lactams.
The numerous genetic rearrangements in the cfxA gene and the presence of various 
genetic mobile elements in oral Capnocytophaga suggest that this genetic site might 
be a reservoir for antibiotic resistance genes and their spread among different 
species. Furthermore, maintenance of this gene, even in an inactive form, might 
contribute to the persistence of antibiotic resistance genes in the oral flora.
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Fig. 1. Detection of blaCSP-1, mobA, cfxA–mobA (junction), oriT, repA, transposons 
(Tn), ISCoc1 and plasmids (presence of at least one plasmid) according to different 
species in clinical cfxA-positive Capnocytophaga isolates.
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